Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
12/1991
12/25/1991CN1057294A Method for recombinant production of hirudins
12/24/1991US5075335 Enzyme inhibitors
12/24/1991US5075308 Method for treating urinary obstruction
12/24/1991US5075230 Stabilized plasminogen activator precursor and method of producing the same
12/24/1991CA1293504C Therapeutic use of tin mesoporphyrin
12/23/1991WO1992000293A1 Bis-benzo or benzopyrido cyclo hepta piperidene, piperidylidene and piperazine compounds and compositions
12/23/1991CA2045257A1 Acyl benzoxazolinones, their preparation process and the pharmaceutical compositions containing them
12/23/1991CA2045256A1 Chalcone, their preparation process and the pharmaceutical compositions containing them
12/21/1991WO1991019707A2 Antiatherosclerotic and antithrombotic 1-benzopyran-4-ones and 2-amino-1,3-benzoxazine-4-ones
12/21/1991CA2081577A1 Antiatherosclerotic and antithrombotic 1-benzopyran-4-ones and 2-amino-1, 3-benzoxazine-4-ones
12/21/1991CA2044977A1 Pharmaceutical combination preparations containing cephalosporin and xanthine derivatives and their use
12/19/1991DE4019080A1 Use of new and known 3,7-di:aza-bi:cyclo(3,3,1)nonane derivs. - as diuretics for treating oedema, coronary insufficiency and hypertonia
12/19/1991CA2043281A1 Benzopyran derivatives and heterocyclic analogs thereof as antiischemic agents
12/18/1991EP0461574A2 Medicines containing 3,7-diazabicyclo(3,3,1)nonanes
12/17/1991CA1293254C Substituted pyrrol-1-ylphenyldihydropyridazinones, their preparation and their use
12/17/1991CA1293214C Process for the preparation of a factor v concentrate
12/17/1991CA1293211C Human tissue plasminogen activator
12/16/1991CA2044673A1 Method of diuretic treatment with 3,7-diazabicyclo[3,3,1] nonane compounds and pharmaceutical compositions therefor
12/15/1991WO1991019793A2 Hybrid plasminogen activators
12/15/1991CA2085224A1 Hybrid plasminogen activators
12/13/1991CA2044191A1 Process for the purification of factor viii and factor viii obtained by said process
12/11/1991EP0460058A1 Use of bactericidal/permeability increasing protein or biologically active analogs thereof for the manufacture of a medicament to treat endotoxin-associated disorders
12/11/1991CN1015054B N-indolylethyl sulphonic acid amides, process for preparation thereof and their use
12/10/1991US5071969 Sulphated k5 antigen and sulphated k5 antigen fragments
12/10/1991US5071961 Adsorption on alpha-hydroxyaminopropyl-modified adsorber, then elution
12/10/1991US5071863 4,5,6,7-trisubstituted benzoxazolones
12/10/1991US5071858 Antipsychotic benzothiopyranylamines
12/04/1991EP0459795A1 Oral dosage form of biologically active proteins
12/04/1991EP0459632A1 Composition and method for controlling cholesterol
12/04/1991EP0459630A2 Polypeptides
12/04/1991EP0459432A1 Treatment of diseases with paf-acether antagonists and procedure for determining their efficacy
12/04/1991EP0459318A2 Method for preventing onset of restenosis after angioplasty employing an ACE inhibitor
12/04/1991EP0458903A1 Soluble analogs of thrombomodulin
12/03/1991US5070139 2,4-disubstituted 1,3-dioxolanes
12/03/1991US5070096 Quinolinoxy phenylsulphonamides
12/03/1991CA1292741C Benzimidazolylpyridazinones
12/02/1991WO1991018602A1 (+)-α-(2,3-DIMETHOXYPHENYL)-1-[2-(4-FLUOROPHENYL)ETHYL]-4-PIPERIDINEMETHANOL
12/01/1991CA2042159A1 Method for preventing onset of restenosis after angioplasty employing an ace inhibitor
11/1991
11/28/1991WO1991017980A1 Disulfide derivatives of mercaptoacylamino acids
11/28/1991WO1991005754A3 Derivatives of long-chain fatty alcohols and their applications, in particular as cytotrophic and cytoprotective molecules, and pharmaceutical compositions containing same
11/27/1991EP0458642A1 Amino bicyclic compounds
11/27/1991EP0458037A1 Bis-aryl amide and urea antagonists of platelet activating factor
11/27/1991EP0201574B1 A preparation for the treatment of hemophilia a inhibitor patients and a process for producing such a preparation
11/27/1991CN1056496A Improvements in and relating to ergoline-8-carboxamides
11/27/1991CN1056494A Bis-aryl amide and urea antagonists of platelet activating factor
11/26/1991US5068340 Antagonist of platelet activating factor for treatment of asthma, inflammation or shock
11/26/1991US5068337 1,4-dihydropyridines and their ability to inhibit blood platelet aggregation, inhibit thromboxane synthetase and phospholipase
11/26/1991US5068332 Alkylidene analogs of 1'-aminospiro[isoquinoline-4(1H),3'-pyrrolidine]-1,2',3,5'(2H)-tetrones useful as aldose reductase inhibitors
11/26/1991US5068244 Benzocyclohexanes and analgesic compositions thereof
11/26/1991US5068236 Xanthine derivatives
11/26/1991US5068106 Tissue plasminogen activator in protein solution
11/22/1991WO1991017987A1 Phenol and pyridinol derivatives as pharmaceuticals
11/22/1991CA2081982A1 Phenol and pyridinol derivatives as pharmaceuticals
11/21/1991EP0457532A1 Monoclonal antibody which inhibits the biological action of platelet factor 4
11/21/1991EP0457371A1 Method for the isolation of the tissue protein PP4
11/21/1991EP0457370A1 Method for the pasteurization of the tissue protein PP4
11/21/1991EP0456835A1 Quinazoline-3-alkanoic acid derivative, salt thereof, and production thereof
11/21/1991EP0456812A1 Megakaryocyte production
11/20/1991CN1014787B Phenoxyacetic acid derivative and processes for preparing same
11/19/1991US5066787 Blood coagulation inhibiting proteins, processes for preparing them and their uses
11/19/1991US5066649 8,9-annelated-1,2,3,4-tetrahydro-β-carboline derivatives
11/19/1991CA1292233C 5-(w-phenethylamino-alkyl)-4,5,6,7-tetrahydro-thieno- (3,2-c)-pyridine derivatives
11/14/1991DE4015136A1 Verfahren zur herstellung von thieno-triazolo-diazepinderivaten Thieno-triazolo-diazepine derivatives process for the preparation of
11/13/1991EP0456279A1 Condensed piperidine derivatives, intermediates and process for their preparation, their use as medicaments and pharmaceutical compositions containing them
11/13/1991EP0456152A2 Peptidamides, their process of preparation and the agents containing these peptides as fibrin-thrombin clotting inhibitors
11/13/1991EP0455726A1 Treatment of leukocyte dysfunction with gm-csf
11/13/1991EP0455722A1 Processes for producing polypeptide inhibitors of platelet activation and methods, combinations and compositions using them
11/13/1991EP0455682A1 Polypeptides having a human beta-adrenergic receptor activity, and playing a role in lipolytic response, nucleic acids coding for these polypeptides and use of said polypeptides for screening substances which act on these polypeptides.
11/13/1991EP0444129A4 Human neutrophilic granulocyte end-stage maturation factor and its preparation and use
11/13/1991EP0412115A4 Hybrid peptides and methods of their use
11/13/1991EP0236385B1 A superoxide dismutase
11/13/1991CN1056056A Composition and method for controlling cholesterol
11/12/1991US5064842 1,4-dihydropyridines
11/12/1991US5064839 1,4-dihydropyridines with a 2-amino group or with an ether group in a side chain
11/12/1991US5064817 Phospholipase a2 inhibiting compositions and their use
11/12/1991CA1292003C Hydroximic acids of 7-oxabicycloheptane substituted ethers and thioethers
11/11/1991WO1991017250A1 Method for the recombinant production of hiridius and hirudin-like polypeptides
11/11/1991CA2063575A1 Method for the recombinant production of hirudins and hirudin-like polypeptides
11/10/1991WO1991017163A1 IMIDAZO (4,5-c) PYRIDINES WITH PAF ANTAGONIST ACTIVITY
11/10/1991WO1991016915A1 Maturation of hemopoietic cells
11/10/1991CA2080476A1 Azabenzimidazoles in the treatment of asthma, arthritis and related diseases
11/10/1991CA2056359A1 Maturation of hemopoietic cells
11/06/1991EP0454736A1 Fibrinolysis by il-4
11/05/1991US5063225 Benzothiazepines
11/05/1991US5063203 Anticoagulants, humans
11/05/1991CA2041687A1 Bis-aryl amide and urea antagonists of platelet activating factor
11/05/1991CA1291754C Fused five-ring heterocyclic compounds, their production, and their pharmaceutical use
11/03/1991CA2040996A1 Composition and method for controlling cholesterol
10/1991
10/31/1991WO1991016437A1 Soluble peptide analogues containing binding sites
10/31/1991WO1991016349A1 Expression of recombinant hemoglobin in yeast
10/31/1991WO1991009118A3 Activatable fibrinolytic and anti-thrombotic proteins
10/31/1991CA2081207A1 Soluble peptide analogues containing binding sites
10/31/1991CA2080589A1 Expression of recombinant hemoglobin in yeast
10/31/1991CA2041454A1 Polypeptides
10/30/1991EP0454651A2 Novel platelet-aggregation inhibitors
10/30/1991EP0454429A2 Use of 15-dehydroxy-16-oxoprostaglandin derivatives in the treatment of allergic diseases
10/30/1991EP0454400A2 Repopulation of macrophages and granulocytes using transforming growth factor-beta
10/30/1991EP0454372A1 Anticoagulant protein and method of production
10/30/1991EP0454084A1 Method of manufacturing iron-fortified beverage
10/30/1991EP0453960A1 Sulfonylamino substituted bicyclyl hydroxamic acid derivatives
1 ... 615 616 617 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 ... 671